User banner image
User avatar
  • admin

Posts

China-Europe Freight Train Service Linking N. China Cangzhou Huanghua Port, Moscow in Regular Operation

CANGZHOU, China, July 9, 2024 /PRNewswire/ — A cargo train carrying 30 twenty-foot equivalent units (TEUs) of containers of goods departed on June 25 from...

UK Beauty 2024: How Brands and Retailers Can Reach Gen Zers and Young Millennials on the Path to Purchase

Dublin, July 09, 2024 (GLOBE NEWSWIRE) — The “UK Beauty 2024: How Brands and Retailers Can Reach Gen Zers and Young Millennials on the Path...

Dassault Systèmes Provides Preliminary Second Quarter 2024 Results and Full Year Outlook

                 Press Release VELIZY-VILLACOUBLAY, France — July 9th, 2024 Dassault Systèmes Provides Preliminary Second Quarter 2024 Results and Full Year Outlook Dassault Systèmes (Euronext Paris:...

Clene Announces 1-for-20 Reverse Stock Split

SALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine...

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

– Abiprubart Phase 2b clinical trial in Sjögren’s Disease to evaluate treatment response across biweekly and monthly subcutaneous administrations – – Abiprubart clinical development in Sjögren’s...

Endomimetics™ Awarded $100,000 Grant from Innovate Alabama to Support Development and Evaluate Potential of Bionanomatrix™ to Reduce Infectious and Inflammatory Complications of Knee Arthroplasty

Grant supplements the $292 thousand one-year NIH/SBIR grant to develop this indication Knee arthroplasty is another example of the broad potential utility of Bionanomatrix™ to...

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global...

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced...

Rokid AR Lite Crowdfunding Exceeds $1 Million with Only 3 Days Left

REDWOOD CITY, Calif., July 9, 2024 /PRNewswire/ — Rokid AR Lite has reached a significant milestone in its Kickstarter campaign, surpassing $1 million in total...

37 Interactive Entertainment’s Near term Targets Have Been Validated By SBTi

WASHINGTON, July 9, 2024 /PRNewswire/ — Recently, 37 Interactive Entertainment’s Near Term targets for promoting greenhouse gas emissions reduction have been officially validated by the Science...